COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 640: Articles 6391-6400  | Next

Incidence and severity of SARS-CoV-2 infections in people with primary ciliary dyskinesia
Pedersen, E. S. L., Schreck, L. D., Goutaki, M., Bellu, S., Copeland, F., Lucas, J. S., Zwahlen, M., COVID-PCD patient advisory group, , Kuehni, C. E.
10.1101/2022.10.14.22281075 — Posted: 2022-10-17
Indirect effects of the first two years of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries.
Wright, F. L., Cheema, K., Goldacre, R., Hall, N., Herz, N., Islam, N., Karim, Z., Moreno-Martos, D., Morales, D. R., O'Connell, D., Spata, E., Akbari, A., Ashworth, M., Barber, M., Briffa, N., Canoy, D., Denaxas, S., Khunti, K., Kurdi, A., Mamas, M., Priedon, R., Sudlow, C., Morris, E. J., Lacey, B., Banerjee, A.
10.1101/2022.10.13.22281031 — Posted: 2022-10-17
Development of hybrid immunity during a period of high incidence of infections with Omicron subvariants: A prospective population based multi-region cohort study
Frei, A., Kaufmann, M., Amati, R., Butty Dettwiler, A., von Wyl, V., Annoni, A. M., Pellaton, C., Pantaleo, G., Fehr, J. S., D'Acremont, V., Bochud, M., Albanese, E., Puhan, M. A.
10.1101/2022.10.14.22281076 — Posted: 2022-10-17
Contraceptive use and pregnancy planning in Britain during the first year of the COVID-19 pandemic: findings from a large, quasi-representative survey (Natsal-COVID)
Baxter, A. J., Geary, R., Dema, E., Boso Perez, R., Riddell, J., Willis, M., Conolly, A., Oakley, L., Copas, A., Gibbs, J., Bonell, C., Sonnenberg, P., Mercer, C. H., Clifton, S., Mitchell, K. R., Field, N.
10.1101/2022.10.14.22281078 — Posted: 2022-10-17
Ethnicity-Specific Effects on Cardiac Arrest During the COVID-19 Pandemic: A Two-Year Prospective Evaluation in a North American Community
Chugh, H. S., Sargsyan, A., Nakamura, K., Uy-Evanado, A., Dizon, B., Norby, F. L., Young, C., Hadduck, K., Jui, J., Shepherd, D., Salvucci, A., Chugh, S., Reinier, K.
10.1101/2022.10.15.22281071 — Posted: 2022-10-17
COVID-19 Vaccine Effectiveness against SARS-CoV-2 Infections with the Delta Variant among Ages >=12 Years in Utah
Mohanty, S., Dawood, F. S., Stanford, J. B., Jazmin, D., Stockwell, M. S., Veguilla, V., Porucznik, C. A.
10.1101/2022.10.13.22281012 — Posted: 2022-10-17
Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes.
Zhang, X., Li, Z., Zhang, Y., Liu, Y., Wang, J., Liu, B., Chen, Q., Wang, Q., Fu, L., Wang, P., Zhong, X., Jin, L., Chen, L., He, J., Zhao, J., Xiong, X.
10.1101/2022.10.14.512296 — Posted: 2022-10-16
SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients
Celikgil, A., Massimi, A. B., Nakouzi, A., Herrera, N. G., Morano, N. C., Lee, J. H., Yoon, H. a., Garforth, S. J., Almo, S. C.
10.1101/2022.10.14.512324 — Posted: 2022-10-16
Serology assays used in SARS-CoV-2 seroprevalence surveys worldwide: a systematic review and meta-analysis of assay features, testing algorithms, and performance
Ma, X., Li, Z., Whelan, M. G., Kim, D., Cao, C., Yanes-Lane, M., Yan, T., Jaenisch, T., Chu, M. C., Clifton, D. A., Subissi, L., Bobrovitz, N., Arora, R. K.
10.1101/2022.10.13.22280957 — Posted: 2022-10-15
Stability of SARS-CoV-2 spike antigens against mutations
Martinez De la Fuente, I., Malaina, I., Fedetz, M., Chruszcz, M., Grandes, G., Targoni, O., Lozano-Perez, A. A., Shteyer, E., Ben Ya'akov, A., Gomez de la Camara, A., M. Borobia, A., Carrasco-Pujante, J., Ignacio Pijoan, J., Bringas, C., Perez-Yarza, G., Ouro, A., Crawford, M. J., Shoshan-Barmatz, V., Zhurov, V., Lopez, J. I., Knafo, S., Tary-Lehmann, M., Gabaldon, T., Grbic, M.
10.1101/2022.10.13.22280980 — Posted: 2022-10-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).